Evidence map›Paper›PMID 27274072›Full record

SynthesisProceedings of the National Academy of Sciences of the United States of America2016

Characterizing treatment pathways at scale using the OHDSI network.

George Hripcsak, Patrick B Ryan, Jon D Duke, Nigam H Shah, Rae Woong Park, Vojtech Huser, Marc A Suchard, Martijn J Schuemie, Frank J DeFalco, Adler Perotte and 7 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 177 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Federated Adaptive Causal Estimation (FACE) of Target Treatment Effects.Journal of the American Statistical Association · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

George HripcsakDepartment of Biomedical Informatics, Columbia University Medical Center, New York, NY 10032; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY 10032; Observational Health Data Sciences and Informatics, New York, NY 10032; hripcsak@columbia.edu.
Patrick B RyanObservational Health Data Sciences and Informatics, New York, NY 10032; Epidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560;
Jon D DukeObservational Health Data Sciences and Informatics, New York, NY 10032; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN 46205;
Nigam H ShahObservational Health Data Sciences and Informatics, New York, NY 10032; Center for Biomedical Informatics Research, Stanford University, CA 94305;
Rae Woong ParkObservational Health Data Sciences and Informatics, New York, NY 10032; Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea, 443-380;
Vojtech HuserObservational Health Data Sciences and Informatics, New York, NY 10032; Lister Hill National Center for Biomedical Communications (National Library of Medicine), National Institutes of Health, Bethesda, MD 20894;
Marc A SuchardObservational Health Data Sciences and Informatics, New York, NY 10032; Department of Biomathematics, University of California, Los Angeles, CA 90095; Department of Biostatistics, University of California, Los Angeles, CA 90095; Department of Human Genetics, University of California, Los Angeles, CA 90095;
Martijn J SchuemieObservational Health Data Sciences and Informatics, New York, NY 10032; Epidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560;
Frank J DeFalcoObservational Health Data Sciences and Informatics, New York, NY 10032; Epidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560;
Adler PerotteDepartment of Biomedical Informatics, Columbia University Medical Center, New York, NY 10032; Observational Health Data Sciences and Informatics, New York, NY 10032;
Juan M BandaObservational Health Data Sciences and Informatics, New York, NY 10032; Center for Biomedical Informatics Research, Stanford University, CA 94305;
Christian G ReichObservational Health Data Sciences and Informatics, New York, NY 10032; Real World Evidence Solutions, IMS Health, Burlington, MA 01809;
Lisa M SchillingObservational Health Data Sciences and Informatics, New York, NY 10032; Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045;
Michael E MathenyObservational Health Data Sciences and Informatics, New York, NY 10032; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37212; Geriatric Research, Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN 37212;
Daniella MeekerObservational Health Data Sciences and Informatics, New York, NY 10032; Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90089; Department of Pediatrics, University of Southern California, Los Angeles, CA 90089;
Nicole PrattObservational Health Data Sciences and Informatics, New York, NY 10032; Division of Health Sciences, University of South Australia, Adelaide, SA, Australia 5001;
David MadiganObservational Health Data Sciences and Informatics, New York, NY 10032; Department of Statistics, Columbia University, New York, NY 10027.

Funding

OMOP information model for eMERGE phenotypingU01HG008680 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Wendy K Chung, GEORGE M HRIPCSAK · 2015 to 2026
$13.3M
DISCOVERING AND APPLYING KNOWLEDGE IN CLINICAL DATABASESR01LM006910 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HRIPCSAK, GEORGE M · 2000 to 2023
$10.6M
Methods for generalized ontology terms enrichment analysisR01LM011369 · NLM · STANFORD UNIVERSITY · PI SHAH, NIGAM H · 2013 to 2020
$5.0M
Mining health data for drug safety profilesR01GM101430 · NIGMS · STANFORD UNIVERSITY · PI SHAH, NIGAM H · 2013 to 2017
$2.9M
NHGRI NIH HHS U01 HG008680NIGMS NIH HHS R01 GM101430NLM NIH HHS R01 LM006910NLM NIH HHS R01 LM011369
6 · The paper itself

Abstract

Observational research promises to complement experimental research by providing large, diverse populations that would be infeasible for an experiment. Observational research can test its own clinical hypotheses, and observational studies also can contribute to the design of experiments and inform the generalizability of experimental research. Understanding the diversity of populations and the variance in care is one component. In this study, the Observational Health Data Sciences and Informatics (OHDSI) collaboration created an international data network with 11 data sources from four countries, including electronic health records and administrative claims data on 250 million patients. All data were mapped to common data standards, patient privacy was maintained by using a distributed model, and results were aggregated centrally. Treatment pathways were elucidated for type 2 diabetes mellitus, hypertension, and depression. The pathways revealed that the world is moving toward more consistent therapy over time across diseases and across locations, but significant heterogeneity remains among sources, pointing to challenges in generalizing clinical trial results. Diabetes favored a single first-line medication, metformin, to a much greater extent than hypertension or depression. About 10% of diabetes and depression patients and almost 25% of hypertension patients followed a treatment pathway that was unique within the cohort. Aside from factors such as sample size and underlying population (academic medical center versus general population), electronic health records data and administrative claims data revealed similar results. Large-scale international observational research is feasible.

Indexed as

Antidepressive AgentsAntihypertensive AgentsDatabases, FactualDepressionDiabetes Mellitus, Type 2Electronic Health RecordsHumansHypertensionHypoglycemic AgentsInternationalityMedical InformaticsPractice Patterns, Physicians'Antidepressive AgentsAntihypertensive AgentsHypoglycemic Agentsdata networkobservational researchtreatment pathways

Identifiers

PMID27274072
PMCPMC4941483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.